Hypofractionated breast radiotherapy for 1 week versus 3 weeks (fast-forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Pathological features of 11,337 patients with primary ductal carcinoma in situ (dcis) and subsequent events: results from the uk sloane project

Cyp3a7*1c allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Intratumoural hydrogen peroxide with radiotherapy in locally advanced breast cancer: results from a phase i clinical trial

Factors affecting covid-19 outcomes in cancer patients: a first report from guy's cancer center in london

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer

Genetic insights into the biological mechanisms governing human ovarian ageing

Breast cancer polygenic risk score and contralateral breast cancer risk

Guy’s cancer cohort – real world evidence for cancer pathways